S C Griffen
Overview
Explore the profile of S C Griffen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rountree A, Reed B, Cummings B, Jung S, Stanhope K, Graham J, et al.
Diabetologia
. 2013 Feb;
56(4):803-13.
PMID: 23404441
Aims/hypothesis: Previous studies on isolated islets have demonstrated tight coupling between calcium (Ca(2+)) influx and oxygen consumption rate (OCR) that is correlated with insulin secretion rate (ISR). To explain these...
2.
Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin
Kasichayanula S, Liu X, Griffen S, Lacreta F, Boulton D
Diabetes Obes Metab
. 2012 Oct;
15(3):280-3.
PMID: 23061428
Aims: Dapagliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that decreases serum glucose by reducing renal glucose reabsorption, thereby promoting urinary glucose excretion. Dapagliflozin is primarily metabolized via...
3.
Cox C, Stanhope K, Schwarz J, Graham J, Hatcher B, Griffen S, et al.
Eur J Clin Nutr
. 2011 Sep;
66(2):201-8.
PMID: 21952692
Background/objectives: The results of short-term studies in humans suggest that, compared with glucose, acute consumption of fructose leads to increased postprandial energy expenditure and carbohydrate oxidation and decreased postprandial fat...
4.
Kasichayanula S, Liu X, Shyu W, Zhang W, Pfister M, Griffen S, et al.
Diabetes Obes Metab
. 2010 Dec;
13(1):47-54.
PMID: 21114603
Aims: Dapagliflozin increases urinary glucose excretion by selectively inhibiting renal sodium-glucose transporter 2, an insulin-independent mechanism of action that may be complementary to that of other oral antidiabetes drugs. The...
5.
Griffen S, Wang J, German M
Diabetes
. 2001 Jan;
50(1):63-8.
PMID: 11147796
Type 2 diabetes is a strongly genetic disorder resulting from inadequate compensatory insulin secretion in the face of insulin resistance. The Zucker diabetic fatty (ZDF) rat is a model of...
6.
Sander M, Griffen S, Huang J, German M
Proc Natl Acad Sci U S A
. 1998 Sep;
95(20):11572-7.
PMID: 9751707
Insulin gene transcription is limited to the beta cells within the mammalian pancreas and, like insulin secretion, is regulated by glucose. Our previous studies in primary cultured beta cells suggested...
7.
Raff H, Rossing M, Doepker S, Griffen S, Jankowski B
Clin Exp Pharmacol Physiol
. 1991 Oct;
18(10):725-9.
PMID: 1764817
1. The aim of the present study was to determine the effect of water restriction and/or hypoxia on the vasopressin response to haemorrhage in conscious rats. 2. Male, Long-Evans rats...
8.
Griffen S, Raff H
J Endocrinol
. 1990 Apr;
125(1):61-6.
PMID: 2338532
The purpose of this study was to determine the effect of water restriction on the vasopressin response to hypoxia in conscious Long-Evans rats. Rats were prepared with chronic indwelling femoral...
9.
Griffen S, Russell S, Katz L, Nicoll C
Proc Natl Acad Sci U S A
. 1987 Oct;
84(20):7300-4.
PMID: 3313390
The functional significance of the portal vascular link between the beta cells of the pancreatic islets and the liver has not been established. Previous studies indicated that insulin does not...